These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7911584)

  • 21. The dynamics of hippocampal sensory gating during the development of morphine dependence and withdrawal in rats.
    Zheng J; Yang Y; Tian S; Chen J; Wilson FA; Ma Y
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):164-8. PubMed ID: 15911142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Memory impairment and auditory evoked potential gating deficit in schizophrenia.
    Hsieh MH; Liu K; Liu SK; Chiu MJ; Hwu HG; Chen AC
    Psychiatry Res; 2004 Feb; 130(2):161-9. PubMed ID: 15033186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential impact of heavy cannabis use on sensory gating in schizophrenic patients and otherwise healthy controls.
    Rentzsch J; Penzhorn A; Kernbichler K; Plöckl D; Gómez-Carrillo de Castro A; Gallinat J; Jockers-Scherübl MC
    Exp Neurol; 2007 May; 205(1):241-9. PubMed ID: 17368620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct forms of prepulse inhibition disruption distinguishable by the associated changes in prepulse-elicited reaction.
    Yee BK; Feldon J
    Behav Brain Res; 2009 Dec; 204(2):387-95. PubMed ID: 19114060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P50 gating at acute and post-acute phases of first-episode schizophrenia.
    Devrim-Uçok M; Keskin-Ergen HY; Uçok A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1952-6. PubMed ID: 18929611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sensory gating of patients with first-episode schizophrenia].
    Chen XS; Zhang MD; Wang HX; Lou CY; Wang JJ; Guo Q; Liu L; Gao CY; Liu P; Liu XW; Duan HJ; Guo FL; Liang JH; Chen C; Chen XW
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3457-9. PubMed ID: 16686059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the PCP analog dizocilpine on sensory gating: potential relevance to clinical subtypes of schizophrenia.
    al-Amin HA; Schwarzkopf SB
    Biol Psychiatry; 1996 Oct; 40(8):744-54. PubMed ID: 8894067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment.
    Cadenhead KS; Light GA; Shafer KM; Braff DL
    Biol Psychiatry; 2005 Jun; 57(12):1504-9. PubMed ID: 15953486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In pursuit of the pathogenesis and pathophysiology of schizophrenia: where do we stand?
    Lewis DA
    Am J Psychiatry; 2002 Sep; 159(9):1467-9. PubMed ID: 12202263
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuronal substrates of sensory gating within the human brain.
    Grunwald T; Boutros NN; Pezer N; von Oertzen J; Fernández G; Schaller C; Elger CE
    Biol Psychiatry; 2003 Mar; 53(6):511-9. PubMed ID: 12644356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal nutritional deprivation as a risk factor in schizophrenia: preclinical evidence.
    Butler PD; Susser ES; Brown AS; Kaufmann CA; Gorman JM
    Neuropsychopharmacology; 1994 Dec; 11(4):227-35. PubMed ID: 7857497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurodevelopmental model of schizophrenia.
    Arch Gen Psychiatry; 1988 Nov; 45(11):1051-4. PubMed ID: 3178412
    [No Abstract]   [Full Text] [Related]  

  • 33. Abnormalities of brain structure and function in schizophrenia: implications for aetiology and pathophysiology.
    Cannon TD
    Ann Med; 1996 Dec; 28(6):533-9. PubMed ID: 9017112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schizophrenia and the brain. Conditions for a neuropsychology of madness.
    Heinrichs RW
    Am Psychol; 1993 Mar; 48(3):221-33. PubMed ID: 8317776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance spectroscopy in schizophrenia: a nascent technology for a neurodevelopmental disorder?
    Buckley PF; Waddington JL
    Biol Psychiatry; 1994 Dec; 36(12):789-91. PubMed ID: 7893843
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical structure of the initial stages of schizophrenia developing against a background of residual cerebral insufficiency].
    Mikhlin VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(3):423-9. PubMed ID: 4156989
    [No Abstract]   [Full Text] [Related]  

  • 37. Quantitative survey of uremic brain dysfunction by auditory evoked potentials.
    Knoll O; Harbort U; Schulte K; Zimpel F
    Adv Neurol; 1982; 32():227-32. PubMed ID: 7054945
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dopamine hypothesis of schizophrenia].
    Yamashita I
    Hokkaido Igaku Zasshi; 1977 Jan; 52(1):74-5. PubMed ID: 559633
    [No Abstract]   [Full Text] [Related]  

  • 39. [Are schizophrenias psychogenic or organic diseases?].
    Leonhard K
    Recenti Prog Med; 1970 Mar; 48(3):235-47. PubMed ID: 5467920
    [No Abstract]   [Full Text] [Related]  

  • 40. Theoretical neurobiology and schizophrenia.
    Friston KJ
    Br Med Bull; 1996 Jul; 52(3):644-55. PubMed ID: 8949263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.